Perceptive Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-838,400
Closed -$25.3M 232
2016
Q2
$25.3M Sell
838,400
-261,600
-24% -$5.31M 1.75% 15
2016
Q1
$12.1M Buy
+1,100,000
New +$3.61M 1.06% 23

Perceptive Advisors's CPXX Position: Q3 2016 in Review

Perceptive Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 838,400 shares — an estimated $25.3M sold.

Perceptive Advisors first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $25.3M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Perceptive Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Perceptive Advisors sold 838,400 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $25.3M.
  • Perceptive Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
  • Perceptive Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $25.3M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.